Research priorities for airway diseases in "long COVID"
O. Elneima (Leicester, United Kingdom), D. Adeloye (Edinburgh , United Kingdom), L. Daines (Edinburgh , United Kingdom), K. Poinasamy (London, United Kingdom), S. Walker (London, United Kingdom), C. Brightling (Leicester, United Kingdom), S. Siddiqui (Leicester, United Kingdom), P. Novotny (Leicester, United Kingdom), J. Hurst (London, United Kingdom), J. Quint (London, United Kingdom), J. Chalmers (Dundee, United Kingdom), P. Pfeffer (London, United Kingdom), T. Drake (Edinburgh , United Kingdom), I. Rudan (Edinburgh , United Kingdom), L. Heaney (Belfast, United Kingdom), A. De Soyza (Newcastle, United Kingdom), A. Sheikh (Edinburgh , United Kingdom)
Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Elneima (Leicester, United Kingdom), D. Adeloye (Edinburgh , United Kingdom), L. Daines (Edinburgh , United Kingdom), K. Poinasamy (London, United Kingdom), S. Walker (London, United Kingdom), C. Brightling (Leicester, United Kingdom), S. Siddiqui (Leicester, United Kingdom), P. Novotny (Leicester, United Kingdom), J. Hurst (London, United Kingdom), J. Quint (London, United Kingdom), J. Chalmers (Dundee, United Kingdom), P. Pfeffer (London, United Kingdom), T. Drake (Edinburgh , United Kingdom), I. Rudan (Edinburgh , United Kingdom), L. Heaney (Belfast, United Kingdom), A. De Soyza (Newcastle, United Kingdom), A. Sheikh (Edinburgh , United Kingdom). Research priorities for airway diseases in "long COVID". 954
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: